Literature DB >> 12478342

Contractile responses to reactive oxygen species in the canine basilar artery in vitro: selective inhibitory effect of MCI-186, a new hydroxyl radical scavenger.

M Tosaka1, Y Hashiba, N Saito, H Imai, T Shimizu, T Sasaki.   

Abstract

BACKGROUND: Cerebral vasospasm is one of the important pathological phenomena which influence morbidity and mortality following subarachnoid haemorrhage. Reactive oxygen species (ROSs) generated by the autoxidation of oxyhemoglobin to methemoglobin may be one of the essential factors in the pathogenesis of cerebral vasospasm. The direct vasocontractile effects of hydrogen peroxide (H(2)O(2)), superoxide anion (O(2)(-)), and hydroxyl radical (*OH) on the canine basilar artery and the inhibitory effects of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one), a new *OH scavenger, were investigated.
METHOD: Isometric tension was recorded in basilar artery rings from dogs in vitro. H(2)O(2), pyrogallol (O(2)(-) donor), and vitamin C (VitC)/Fe(2+) (*OH-generating system) were used to generate the ROSs.
FINDINGS: H(2)O(2) (10 micromol/L), pyrogallol (10 micromol/L), and VitC/Fe(2+) (100 micromol/L each) induced fast onset and transient, slow onset and transient, and sustained contraction, respectively, in the canine basilar artery. Contractions induced by H(2)O(2) were almost completely inhibited by pre-incubation with catalase (800 U/mL) and those by pyrogallol with superoxide dismutase (150 U/mL), but neither with MCI-186 (10 micromol/L). The contraction induced by VitC/Fe(2+) was clearly inhibited by pre-incubation with MCI-186, but not with catalase or superoxide dismutase.
INTERPRETATION: ROSs have direct vasocontractile effects on the canine basilar artery in vitro, but different ROSs have different contractile characteristics. Such contractions might be related to the pathophysiology of cerebral vasospasm. MCI-186 had a clear and selective inhibitory effect against *OH-induced contraction in vitro. Comparison of different radical scavengers may be important in pharmacological assessment, especially targeted on cerebral vasospasm.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478342     DOI: 10.1007/s00701-002-1020-8

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

Review 1.  Role of endothelial nitric oxide in cerebrovascular regulation.

Authors:  Dmitriy N Atochin; Paul L Huang
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

2.  Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.

Authors:  Kiyoshi Kikuchi; Ko-Ichi Kawahara; Hisaaki Uchikado; Naohisa Miyagi; Terukazu Kuramoto; Tomoya Miyagi; Yoko Morimoto; Takashi Ito; Salunya Tancharoen; Naoki Miura; Kazunori Takenouchi; Yoko Oyama; Binita Shrestha; Fumiyo Matsuda; Yoshihiro Yoshida; Shinihiro Arimura; Kentaro Mera; Ko-Ichi Tada; Narimasa Yoshinaga; Ryuichi Maenosono; Yoshiko Ohno; Teruto Hashiguchi; Ikuro Maruyama; Minoru Shigemori
Journal:  Exp Ther Med       Date:  2011-06-07       Impact factor: 2.447

Review 3.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

4.  Edaravone improves the survival of rats subjected to hemorrhagic shock without resuscitation.

Authors:  Yoshitaka Uji; Hiroshi Yamamoto; Tsuyoshi Mori; Hiroya Akabori; Hiroshi Tsuchihashi; Tomoharu Shimizu; Yoshihiro Endo; Tohru Tani
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

5.  Dexanabinol prevents development of vasospasm in the rat femoral artery model.

Authors:  Ramazan Durmaz; Ahmet Ozsandik; Varol Sahintürk; Kismet Civi; Cengiz Bayçu; Hilmi Ozden; Amselem Shimon
Journal:  Neurosurg Rev       Date:  2008-02-07       Impact factor: 3.042

Review 6.  The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.

Authors:  Kiyoshi Kikuchi; Salunya Tancharoen; Nobuyuki Takeshige; Munetake Yoshitomi; Motohiro Morioka; Yoshinaka Murai; Eiichiro Tanaka
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923

7.  In vitro antioxidant and in vivo antidepressant activity of green synthesized azomethine derivatives of cinnamaldehyde.

Authors:  Sridevi Chigurupati; Sohrab Akhtar Shaikh; Jahidul Islam Mohammad; Kesavanarayanan Krishnan Selvarajan; Appala Raju Nemala; Chu How Khaw; Chun Foo Teoh; Ting Hei Kee
Journal:  Indian J Pharmacol       Date:  2017 May-Jun       Impact factor: 1.200

8.  Edaravone attenuates sustained pial arteriolar vasoconstriction independently of endothelial function after unclamping of the abdominal aorta in rabbits.

Authors:  Tomohiro Michino; Kumiko Tanabe; Motoyasu Takenaka; Shigeru Akamatsu; Masayoshi Uchida; Mami Iida; Hiroki Iida
Journal:  Korean J Anesthesiol       Date:  2021-06-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.